COMMUNIQUÉS West-GlobeNewswire

Opening of new Dutch wind farm puts Philips on course to becoming carbon neutral by 2020
16/05/2019
May 16, 2019 On-schedule opening of Windpark Krammer by Dutch monarch makes Philips’ Netherlands-based operations 100% powered by renewable energy Combined with the 100% target already achieved in the US, Philips is now [...]
LIDDS Delårsrapport januari - mars 2019
16/05/2019
JANUARI - MARS 2019 Nettoomsättningen uppgick till 0,0 (0,0) KSEK Kostnaderna uppgick till 2,5 (2,0) MSEK Resultatet före och efter skatt uppgick till -2,5 (-2,0) MSEK Resultat per aktie uppgick till -0,11 (-0,09) kr [...]
Terveystalo's network of occupational health services to expand: Terveystalo acquires Etelä-Karjalan Työkunto Oy
16/05/2019
Press Release 16 May 2019 Terveystalo will buy the operations of Etelä-Karjalan Työkunto Oy by an agreement signed on 15 May 2019. The old customer relationship remains unchanged. Etelä-Karjalan Työkunto Oy is the [...]
Novadip Biosciences to present at 20th annual Bio€quity Europe Conference
16/05/2019
Novadip Biosciences to present at 20 th annual Bio€quity Europe Conference Belgium, 16 May 2019: Novadip Biosciences (“Novadip”), a regenerative medicine company and pioneer in the development of three-dimensional [...]
AroCell AB (publ) Interim Report 1st January to 31st March 2019
16/05/2019
Word from the CEO “Biomarkers will play an increasingly important role in how we identify and follow up treatments for patients with cancer in the coming years. The development of an increased individual adaptation of [...]
Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma
16/05/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID TO TREAT ALLERGIC ASTHMA « Antibodies and Complement 2019 » - Girona, [...]
Néovacs présente les résultats précliniques de son candidat vaccin thérapeutique IL-4 / IL-13 Kinoïde pour le traitement de l'asthme allergique
16/05/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTE LES R É SULTATS PR É CLINIQUES DE SON CANDIDAT VACCIN TH É RAPEUTIQUE IL-4/IL-13 KINO Ϊ DE POUR LE TRAITEMENT DE L’ASTHME ALLERGIQUE « [...]
ObsEva SA to Participate in Upcoming Investor Conferences
16/05/2019
Geneva, Switzerland and Boston, MA – May 16, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Renaissance BioScience files PCT Patent Application for Yeast-based RNA Bioactive Molecule Production and Delivery Technology Platform
16/05/2019
VANCOUVER, British Columbia, May 16, 2019 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp., a leading biological engineering company, is pleased to announce the filing on May 8, 2019 of a PCT patent application for a [...]
“CADScor®System will shorten waiting lists and add value for both patients and healthcare system” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in Wolkersdorf, Austria
16/05/2019
Interim Report, January – March 2019 Malmö, May 16, 2019 “CADScor®System will shorten waiting lists and add value for both patients and healthcare system” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in [...]
Biocartis Group NV: Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference
16/05/2019
PRESS RELEASE : 16 May 2019, 07:00 CEST Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference Mechelen, Belgium, 16 May 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials
16/05/2019
Sym021 a novel anti-PD1 compound currently in Phase 1 clinical trials Copenhagen, 16 May 2019 – Symphogen, a private clinical stage oncology focused biopharmaceutical company with a productive antibody discovery engine [...]
Guardant Health to Present Precision Oncology Data Across the Continuum of Care at the ASCO Annual Meeting
16/05/2019
REDWOOD CITY, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), along with researchers from leading academic institutions and pharmaceutical companies, will present 27 abstracts at the ASCO [...]
MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
16/05/2019
LA JOLLA, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Veritas Announces Restructuring of Cannevert Therapeutics Ltd.
15/05/2019
VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has undertaken steps to restructure and rebuild [...]
Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs
15/05/2019
Patients with advanced cervical cancer treated with LN-145 had an objective response rate of 44 percent Patients in Cohort 2 with advanced melanoma treated with lifileucel following failure of checkpoint inhibitors had [...]
CytomX Therapeutics Announces Presentations at 2019 ASCO Annual Meeting
15/05/2019
SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX) a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Synthorx to Present at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
15/05/2019
SAN DIEGO, May 15, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company discovering and developing optimized biologics for cancer and autoimmune disorders, today announced company researchers [...]
MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer
15/05/2019
Study meets first sequential primary endpoint of progression-free survival (PFS) in head-to-head with current standard of care (trastuzumab and chemotherapy) Oral abstract will be presented at American Society of [...]

Pages